FDA Approves First Biosimilar Drug

The FDA approved its first “biosimilar” drug, a decision expected to launch a new industry of lower-cost versions of expensive drugs that could help the U.S. curb its $300 billion in yearly drug spending.



from WSJ.com: US Business http://ift.tt/1x0kcAb

via IFTTT